The silent pandemic: how drug-resistant superbugs risk becoming the world’s number one killer
Antimicrobial resistance has been rising for years, but a spike in antibiotic use during the COVID-19 pandemic has accelerated the process.
Read articleThe silent pandemic: how drug-resistant superbugs risk becoming the world’s number one killer
Antimicrobial resistance has been rising for years, but a spike in antibiotic use during the COVID-19 pandemic has accelerated the process.
Read article“It’s difficult, but we’ll find a way”: a new vaccine against typhoid rolls out in a flood-devastated province of Pakistan
Armed with vials of Typhoid Conjugate Vaccine, health workers in Balochistan are doing what they can to protect children threatened by a pincer movement of global crises: antimicrobial resistance on the one hand and climate change on the other.
Read article“It’s difficult, but we’ll find a way”: a new vaccine against typhoid rolls out in a flood-devastated province of Pakistan
Armed with vials of Typhoid Conjugate Vaccine, health workers in Balochistan are doing what they can to protect children threatened by a pincer movement of global crises: antimicrobial resistance on the one hand and climate change on the other.
Read articleAnnual Progress Report 2021
Highlighting key data, partnerships and milestones, the first report of our 2021–2025 strategic period offers insights into our progress last year, while facing the challenges ahead – including the Vaccine Alliance’s role in the global COVID-19 response.
Explore the reportAnnual Progress Report 2021
Highlighting key data, partnerships and milestones, the first report of our 2021–2025 strategic period offers insights into our progress last year, while facing the challenges ahead – including the Vaccine Alliance’s role in the global COVID-19 response.
Explore the reportWild polio returns to Africa: How the GPEI is helping stop an outbreak from becoming an inferno
In February 2022, a year and a half after the continent was declared indigenous wild poliovirus-free, the virus resurfaced in south-eastern Africa. As the Global Polio Eradication Initiative kicks off pledging to fund the 2022-2026 strategy, VaccinesWork dives into what exactly happened in Malawi and Mozambique, where eight children have been paralysed by an infectious threat that really isn’t over until it’s over everywhere.
ExploreWild polio returns to Africa: How the GPEI is helping stop an outbreak from becoming an inferno
In February 2022, a year and a half after the continent was declared indigenous wild poliovirus-free, the virus resurfaced in south-eastern Africa. As the Global Polio Eradication Initiative kicks off pledging to fund the 2022-2026 strategy, VaccinesWork dives into what exactly happened in Malawi and Mozambique, where eight children have been paralysed by an infectious threat that really isn’t over until it’s over everywhere.
ExploreCOVAX: key learnings for future pandemic preparedness and response
Drawing on COVAX’s unique experience enabling an unprecedented global rollout at scale during a pandemic, this paper outlines the key challenges the mechanism faced in seeking to ensure equitable access to COVID-19 vaccines, the actions it took in response and recommendations for the future.
Read moreCOVAX: key learnings for future pandemic preparedness and response
Drawing on COVAX’s unique experience enabling an unprecedented global rollout at scale during a pandemic, this paper outlines the key challenges the mechanism faced in seeking to ensure equitable access to COVID-19 vaccines, the actions it took in response and recommendations for the future.
Read moreAbout our Alliance
As part of its mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 981 million children in the world’s poorest countries, preventing more than 16.2 million future deaths.
Who we areAbout our Alliance
As part of its mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 981 million children in the world’s poorest countries, preventing more than 16.2 million future deaths.
Who we are